Related Experiment Video
Updated: Mar 6, 2026
Technical Detail for Robot Assisted Pancreaticoduodenectomy
Published on: September 28, 2019
Maximum surgical blood order schedule for pancreatoduodenectomy: a long way from uniform applicability!
Savio G Barreto1,2,3, Amanjeet Singh1, Azhar Perwaiz1
1Department of Gastrointestinal Surgery, Gastrointestinal Oncology, & Bariatric Surgery, Medanta Institute of Digestive & Hepatobiliary Sciences, Medanta, The Medicity, Gurgaon, India.
Background:
Unnecessary preoperative ordering of blood and blood products results in wastage of a valuable life-saving resource and poses a significant financial burden on healthcare systems.
Aim:
To determine patient-specific factors associated with intra-operative transfusions, and if intra-operative blood transfusions impact postoperative morbidity.
Patients & Methods:
Analysis of consecutive patients undergoing pancreatoduodenectomy (PD) for pancreatic tumors.
Results:
A total of 384 patients underwent a classical PD with an estimated median blood loss of 200 cc and percentage transfused being 9.6%. Pre-existing hypertension, synchronous vascular resection, end-to-side pancreaticojejunostomy and nodal disease burden significantly associated with the need for intra-operative transfusions. Intra-operative blood transfusion not associated with postoperative morbidity.
Conclusion:
Optimization of MSBOS protocols for PD is required for more judicious use of blood products.
